NGL Fine Chem Q1 FY27 results: Revenue up 34%, PAT nearly doubles YoY

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF Explain this filing

NGLFINE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.4%Reaction day

₹3415.00

prior close

₹3517.90

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%+0.2% vs market

Pharmaceuticals peers, median of 166sector+0.1%+0.2% vs sector

On the reaction day the stock moved 0.2 pts more than Nifty Microcap 250 and 0.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

-0.1

15m

-0.5

30m

-2.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.4+0.2+0.2+0.1+0.2

Next day

+2.0+0.2+1.8-0.3+2.3

-15.1+0.4-15.4-0.2-14.9

-10.5+0.7-11.3-0.1-10.4

-11.1+0.1-11.3-1.4-9.7

-11.4+0.7-12.1-0.8-10.6

-15.8+1.2-16.9-0.5-15.2

15d

-12.4+0.7-13.1+0.3-12.7

-24.7-1.2-23.5-0.0-24.7

-16.0-1.1-14.8-2.3-13.7

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 166Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NGL Fine Chem posted strong Q1 FY27 results. Standalone revenue rose 35.5% YoY to Rs 13,671 lakhs and PAT jumped 115% to Rs 1,645 lakhs. Consolidated revenue grew 33.6% to Rs 13,916 lakhs with PAT up 99% at Rs 1,840 lakhs. Standalone EPS more than doubled to Rs 26.63. Margins expanded sharply with standalone PBT margin reaching about 16%. Auditor issued a clean limited review.

Likely market impact

Strong beat on both revenue and profits with margins expanding sharply. Positive read for shareholders; likely to be well received by the market.